These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 9847926)

  • 81. Neuropsychiatric adverse effects of oseltamivir in the FDA Adverse Event Reporting System, 1999-2012.
    Hoffman KB; Demakas A; Erdman CB; Dimbil M; Doraiswamy PM
    BMJ; 2013 Jul; 347():f4656. PubMed ID: 23881998
    [No Abstract]   [Full Text] [Related]  

  • 82. Breast pump adverse events: reports to the food and drug administration.
    Brown SL; Bright RA; Dwyer DE; Foxman B
    J Hum Lact; 2005 May; 21(2):169-74. PubMed ID: 15886342
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Silicone: a critical review.
    Duffy DM
    Adv Dermatol; 1990; 5():93-107; discussion 108-9. PubMed ID: 2204381
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Commentary: are breast implants safe?
    Zuckerman D
    Plast Surg Nurs; 2002; 22(2):66-71. PubMed ID: 12244763
    [No Abstract]   [Full Text] [Related]  

  • 85. Adverse Events Involving Radiation Oncology Medical Devices: Comprehensive Analysis of US Food and Drug Administration Data, 1991 to 2015.
    Connor MJ; Marshall DC; Moiseenko V; Moore K; Cervino L; Atwood T; Sanghvi P; Mundt AJ; Pawlicki T; Recht A; Hattangadi-Gluth JA
    Int J Radiat Oncol Biol Phys; 2017 Jan; 97(1):18-26. PubMed ID: 27979446
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Breast implant related anaplastic large cell lymphoma presenting as late onset peri-implant effusion.
    Smith TJ; Ramsaroop R
    Breast; 2012 Feb; 21(1):102-4. PubMed ID: 21840718
    [TBL] [Abstract][Full Text] [Related]  

  • 87. ECRI institute recommends reporting EMI events.
    Health Devices; 2010 Dec; 39(12):456-7. PubMed ID: 21309308
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Role of postmarketing surveillance in contemporary medicine.
    Woodcock J; Behrman RE; Dal Pan GJ
    Annu Rev Med; 2011; 62():1-10. PubMed ID: 20809798
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Food and Drug Administration's adverse drug reaction monitoring program.
    Lee B; Turner WM
    Am J Hosp Pharm; 1978 Aug; 35(8):929-32. PubMed ID: 677138
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Medical device adverse event reports and the Food and Drug Administration.
    Greenfield LJ
    J Vasc Surg; 2004 Aug; 40(2):395-6. PubMed ID: 15297842
    [No Abstract]   [Full Text] [Related]  

  • 91. [Breast implants and their history].
    Muller GH
    Ann Chir Plast Esthet; 1996 Dec; 41(6):666-75. PubMed ID: 9768176
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Halo and spillover effect illustrations for selected beneficial medical devices and drugs.
    Kerger BD; Bernal A; Paustenbach DJ; Huntley-Fenner G
    BMC Public Health; 2016 Sep; 16():979. PubMed ID: 27630095
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Breast Implant-Related Adverse Events During Mammography: An Assessment of the Food and Drug Administration Manufacturer and User Facility Device Experience Database.
    Normandin S; Safran T; Abi-Rafeh J; Tremblay F; Winocour SJ; Chu C; Davison PG; Vorstenbosch J
    Ann Plast Surg; 2022 Sep; 89(3):261-266. PubMed ID: 35993683
    [TBL] [Abstract][Full Text] [Related]  

  • 94. The ban on breast implants medical or political issue? The rest of the story.
    Arroyave E; Norman HG
    J Fla Med Assoc; 1994 Jul; 81(7):479-83. PubMed ID: 7964575
    [No Abstract]   [Full Text] [Related]  

  • 95. [Statistic analysis of 1900 adverse events of medical device reports].
    Lianying S; Sikang X
    Zhongguo Yi Liao Qi Xie Za Zhi; 2010 Jan; 34(1):53-6. PubMed ID: 20391929
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Maybe now is the time to lift the ban on silicone breast implants.
    Sims S; Lundberg GD
    Plast Surg Nurs; 2002; 22(2):63-5. PubMed ID: 12244762
    [No Abstract]   [Full Text] [Related]  

  • 97. The breast-implant controversy: a medico-moral critique.
    Ward CM
    Br J Plast Surg; 2001 Jun; 54(4):352-7. PubMed ID: 11355993
    [No Abstract]   [Full Text] [Related]  

  • 98. Assessment of the FDA backgrounder on platinum in silicone breast implants: implications for public health policy.
    Maharaj SV
    Int J Health Serv; 2008; 38(1):95-102. PubMed ID: 18341124
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Silicone breast implants. Can emerging medical, legal, and scientific concepts be reconciled?
    Snyder JW
    J Leg Med; 1997 Jun; 18(2):133-220. PubMed ID: 9230567
    [No Abstract]   [Full Text] [Related]  

  • 100. Reporting breast implant complications.
    Wyatt JP
    Plast Surg Nurs; 2003; 23(2):49-54. PubMed ID: 14533570
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.